Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1406-1412

  Szelei, Jozsef ^a   Jimenez, Jesus ^a   Soto, Ana M ^a   Luizzi, Maria F ^a   Sonnenschein, Carlos ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; ESTROGEN;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

EID: 0030898756     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5047     Document Type: Article

References (38)

1. Bruchovsky N, Lesser B, Van Doorn E, Craven S 1975 Hormonal effects on cell proliferation in rat prostate. Vitam Horm 33:61-102
2. Soto AM, Sonnenschein C 1987 Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocr Rev 8:44-52
3. Sonnenschein C, Olea N, Pasanen ME, Soto AM 1989 Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res 49:3474-3481
4. Sonnenschein C, Soto AM, Michaelson CL 1996 Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol 59:147-154
5. Sonnenschein C, Szelei J, Nye TL, Soto AM 1994 Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants. Oncol Res 6:373-381
6. Soto AM, Lin TM, Sakabe K, Olea N, Damassa DA, Sonnenschein C 1995 Variants of the human prostate LNCaP cell line as a tool to study discrete components of the androgen-mediated proliferative response. Oncol Res 7:545-558
7. Soto AM, Sonnenschein C 1985 The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem 23:87-94
8. Damassa DA, Lin TM, Sonnenschein C, Soto AM 1991 Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells. Endocrinology 129:75-84
9. Chang C, Kokontis J, Liao S 1988 Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 85:7211-7215
10. Szelei J, Varadi L, Muller F, Erdelyi F, Orban L, Horvath L, Duda E 1994 Liposome-mediatecl gene transfer in fish embryos. Transgenic Res 384:116-119
11. Gorman CM, Rigby PW, Lane DP 1985 Negative regulation of viral enhancers in undifferentiated embryonic stem cells. Cell 42:519-526
12. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
13. Soto AM, Silvia RM, Sonnenschein C 1992 A plasma-borne specific inhibitor of the proliferation of human estrogen-sensitive breast tumor cells (estrocolyone-I). J Steroid Biochem Mol Biol 43:703-712
14. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ 1979 Establishing and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15:659-670
15. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y 1987 The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
16. Barnes D, Sato G 1980 Serum-free cell culture: an unifying approach. Cell 22:649-655
17. Weinberg RA 1989 Positive and negative controls on cell growth. Biochemistry 28:8263-8269
18. Sonnenschein C, Soto AM 1991 Cell proliferation in Metazoans: negative control mechanisms. In: Lippman ME, Dickson RB (eds) Regulatory Mechanisms in Breast Cancer. Kluwer, Boston, pp 171-194
19. Soto AM, Sonnenschein C 1993 Regulation of cell proliferation: is the ultimate control positive or negative? In: Iversen OH (ed) New Frontiers in Cancer Causation. Taylor and Francis, Washington DC, pp 109-123
20. Horwitz KB, Costlow ME, McGuire WL 1975 MCF-7: a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 26:785-795
21. Zava DT, Chamness GC, Horwitz KB, McGuire WL 1977 Human breast cancer:biologically active estrogen receptor in the absence of estrogen? Science 197:663-664
22. Zava DT, McGuire WL 1978 Human breast cancer: androgen action mediated by estrogen receptor. Science 199:787-788
23. MacIndoe JH, Woods GR, Lee FJ 1981 The specific binding of androgens and the subsequent distribution of androgen-receptor complexes within MCF-7 human breast cancer cells. Steroids 38:439-452
24. Jiang S-Y, Jordan VC 1992 Growth regulation of estrogen-receptor negative breast cancer cells transfected with cDNAs for estrogen receptor. J Natl Cancer Inst 84:580-591
25. Gaben A, Mester J 1991 BALB/C mouse 3T3 fibroblasts expressing human estrogen receptor: effect of estradiol on cell growth. Biochem Biophys Res Commun 176/3:1473-1481
26. Garcia M, Derocq D, Freiss G, Rochefort H 1993 Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 89:11538-11542
27. Zajchowski DA, Sager R, Webster L 1993 Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 53:5004-5011
28. Ma ZQ, Spreafico E, Pollio G, Santagati S, Conti E, Cattaneo E, Maggi A 1993 Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc Natl Acad Sci USA 90:3740-3744
29. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F, Keating A 1943 Androgeninduced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transtected with a human androgen receptor complementary DNA. Cancer Res 53:1304-1311
30. Lundholt BK, Madsen MW, Lykkesfeld AE, Peterson OW, Briand P 1996 Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA. Mol Cell Endocrinol 119:47-59
31. Marcelli M, Haidacher SJ, Plymate SR, Birnbaum RS 1995 Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Endocrinology 136:1040-1048
32. Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB 1995 Androgen upregulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Cancer Res 55:3197-3203
33. Lustig RH, Hua P, Smith LS, Wang C, Chang C 1994 An in vitro model for the effects of androgen on neurons employing androgen receptor-transfected PC12 cells. Mol Cell Neurosci 5:587-596
34. Lin TM, Sonnenschein C, Soto AM, Proliferative patterns of androgen-resistant human prostate cell variants. Program of the 73rd Annual Meeting of The Endocrine Society, Washington DC,1991, p 168 (Abstract)
35. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD 1995 Androgens induced divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52:459-467
36. Kim IY, Kim J-H, Zelner DJ, Ahn H-J, Sensibar JA, Lee C 1996 Transforming growth factor-β1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP. Endocrinology 137:991-999
37. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C, Genetic change in transforming growth factor-β receptor type I gene correlates with insensitivity to transforming growth factor-β1 in human prostate cancer cells. Program of the 87th Annual Meeting of the American Association for Cancer Research, Washington DC, 1996, p 124 (Abstract)
38. Geck P, Szelei J, Jimenez J, Soto AM, Sonnenschein C, Androgen induced proliferative shutoff in prostate cancer cells. Program of the 87th Annual Meeting of the American Association for Cancer Research, Washington DC, 1996, p 223 (Abstract)